Epidemiology of the Antiphospholipid Antibody Syndrome
Tóm tắt
Từ khóa
Tài liệu tham khảo
Petri, 1987, The frequency of lupus anticoagulant in systemic lupus erythematosus: a study of 60 consecutive patients by activated partial thromboplastin time, Russell viper venom time, and anticardiolipin antibody, Ann. Int. Med., 106, 524, 10.7326/0003-4819-106-4-524
Vaarala, 1986, Anticardiolipin response in acute infections, Clin. Immunol. Immunopathol., 41, 8, 10.1016/0090-1229(86)90046-2
Brandt, 1995, Criteria for the diagnosis of lupus anticoagulants: an update, Thromb. Haemost., 74, 1185, 10.1055/s-0038-1649901
El-Roeiy, 1988, Definition of normal autoantibody levels in an apparently healthy population, Obstet. Gynecol., 72, 596
Briley, 1989, Neurological disease associated with antiphospholipid antibodies, Ann. Neurol., 25, 221, 10.1002/ana.410250303
Fields, 1989, The prevalence of anticardiolipin antibodies in a healthy elderly population and its association with antinuclear antibodies, J. Rheumatol., 16, 623
Lockwood, 1989, The prevalence and biologic significance of lupus anticoagulant and anticardiolipin antibodies in a general obstetric population, Am. J. Obstet. Gynecol., 161, 369, 10.1016/0002-9378(89)90522-X
Infante-Rivard, 1991, Lupus anticoagulants, anticardiolipin antibodies, and fetal loss. A case-control study, N. Engl. J. Med., 325, 1063, 10.1056/NEJM199110103251503
Perez, 1991, Anticardiolipin antibodies in unselected pregnant women in relationship to fetal outcome, J. Perinatol., 11, 33
Pattison, 1993, Antiphospholipid antibodies in pregnancy: prevalence and clinical associations, Br. J. Obstet. Gynaecol., 100, 909, 10.1111/j.1471-0528.1993.tb15105.x
Phadke, 1993, Anticardiolipin antibodies in ischaemic heart disease: marker or myth?, Br. Heart J., 69, 391, 10.1136/hrt.69.5.391
Juby, 1998, Prevalence and disease associations of certain autoantibodies in elderly patients, Clin. Invest. Med., 21, 4
Manoussakis, 1987, High prevalence of anti-cardiolipin and other autoantibodies in a healthy elderly population, Clin. Exp. Immunol., 69, 557
Chakravarty, 1990, Anticardiolipin antibody associated ischaemic strokes in elderly patients without systemic lupus erythematosus, Age Ageing, 19, 114, 10.1093/ageing/19.2.114
Cervera, 1990, Isotype distribution of anticardiolipin antibodies in systemic lupus erythematosus: prospective analysis of a series of 100 patients, Ann. Rheum. Dis., 49, 109, 10.1136/ard.49.2.109
Mayumi, 1991, Haemostatic factors associated with vascular thrombosis in patients with systemic lupus erythematosus and the lupus anticoagulant, Ann. Rheum. Dis., 50, 543, 10.1136/ard.50.8.543
Wong, 1991, Outcome of pregnancy in patients with systemic lupus erythematosus: a prospective study, Arch. Intern. Med., 151, 269, 10.1001/archinte.1991.00400020043010
Cervera, 1993, Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients, Medicine, 72, 113, 10.1097/00005792-199303000-00005
Alarcón-Segovia, 1989, Antiphospholipid antibodies and the antiphospholipid syndrome in systemic upus erythematosus: a prospective analysis of 500 consecutive patients, Medicine, 68, 353, 10.1097/00005792-198911000-00003
Buchanan, 1989, Antiphospholipid antibodies in the connective tissue diseases: their relation to the antiphospholipid syndrome and Forme Fruste Disease, J. Rheumatol., 16, 757
Worrall, 1990, SLE: a rheumatological view. Analysis of the clinical features, serology and immunogenetics of 100 SLE patients during long-term follow-up, Q. J. Med., 74, 319
Jones, 1991, Anticardiolipin antibodies in patients from Malaysia with systemic lupus erythematosus, Ann. Rheum. Dis., 50, 173, 10.1136/ard.50.3.173
Picillo, 1992, Longitudinal survey of anticardiolipin antibodies in systemic lupus erythematosus, Scand. J. Rheumatol., 21, 271, 10.3109/03009749209099241
Kutteh, 1993, Association of anticardiolipin antibodies and pregnancy loss in women with systemic lupus erythematosus, Fertil. Steril., 60, 449, 10.1016/S0015-0282(16)56159-7
Axtens, 1994, Single anticardiolipin measurement in the routine management of patients with systemic lupus erythematosus, J. Rheumatol., 21, 91
Petri, 1997, Clinical and management aspects of the antiphospholipid syndrome, 57
Love, 1990, Antiphospholipid antibodies, anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders, Ann. Intern. Med., 112, 682, 10.7326/0003-4819-112-9-682
Papadopolous, 1999, Antiphospholipid antibodies and venous thrombosis (VT) in SLE [abstract], Arthritis Rheum., 42, S369
Ginsburg, 1992, Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis, Ann. Int. Med., 117, 997, 10.7326/0003-4819-117-12-997
Schulman, 1998, Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy, Am. J. Med., 104, 332, 10.1016/S0002-9343(98)00060-6
Mateo, 1997, Laboratory evaluation and clinical characteristics of 2,132 consecutive unselected patients with venous thromboembolism—results of the Spanish Multicentric Study on Thrombophilia (EMET-Study), Thromb. Haemost., 77, 444, 10.1055/s-0038-1655986
Bick, 1998, Syndromes of thrombosis and hypercoagulability. Congenital and acquired causes of thrombosis, Med. Clin. North Am., 82, 409, 10.1016/S0025-7125(05)70004-3
Eschwege, 1998, Prevalence of antiphospholipid-related antibodies in unselected patients with history of venous thrombosis, Blood Coagul. Fibrin., 9, 429, 10.1097/00001721-199807000-00005
Salomon, 1999, Single and combined prothrombotic factors in patients with idiopathic venous thromboembolism: prevalence and risk assessment, Arterioscler. Thromb. Vasc. Biol., 19, 511, 10.1161/01.ATV.19.3.511
Zanon, 1999, Anti-beta2-glycoprotein I antibodies in patients with acute venous thromboembolism: prevalence and association with recurrent thromboembolism, Thromb. Res., 96, 269, 10.1016/S0049-3848(99)00105-X
Wahl, 1997, Risk for venous thrombosis related to antiphospholipid antibodies in systemic lupus erythematosus—a meta-analysis, Lupus, 6, 467, 10.1177/096120339700600510
Palusuo, 1997, High antibody levels to prothrombin imply a risk of deep venous thrombosis and pulmonary embolism in middle-aged men—a nested case-control study, Thromb. Haemost., 78, 1178, 10.1055/s-0038-1657711
Heron, 2000, Hypercoagulable states in primary upper-extremity deep vein thrombosis, Arch. Intern. Med., 160, 382, 10.1001/archinte.160.3.382
Vaarala, 1995, Anti-cardiolipin antibodies and risk of myocardial infarction in a prospective cohort of middle-aged men, Circulation, 91, 23, 10.1161/01.CIR.91.1.23
Levine, 1992, Risk of recurrent thromboembolic events in patients with focal cerebral ischemia and antiphospholipid antibodies, Stroke, 23, I29
Hart, 1984, Cerebral infarction associated with lupus anticoagulants—preliminary report, Stroke, 15, 114, 10.1161/01.STR.15.1.114
Chancellor, 1989, Etiology, prognosis, and hemostatic function after cerebral infarction in young adults, Stroke, 20, 477, 10.1161/01.STR.20.4.477
Brey, 1990, Antiphospholipid antibodies and cerebral ischemia in young people, Neurology, 40, 1190, 10.1212/WNL.40.8.1190
Czlonkowska, 1992, Anticardiolipin antibodies, a disease marker for ischemic cerebrovascular events in a younger patient population?, Acta Neurol. Scand., 86, 304, 10.1111/j.1600-0404.1992.tb05090.x
de Jong, 1993, Cardiolipin antibodies and lupus anticoagulant in young patients with a cerebrovascular accident in the past, Neth. J. Med., 42, 93
Ferro, 1993, Lupus anticoagulant and the fibrinolytic system in young patients with stroke, Stroke, 24, 368, 10.1161/01.STR.24.3.368
Tietjen, 1993, Factors that predict antiphospholipid immunoreactivity in young people with transient focal neurological events, Arch. Neurol., 50, 833, 10.1001/archneur.1993.00540080042011
Hess, 1991, Anticardiolipin antibodies: a study of frequency in TIA and stroke, Neurology, 41, 525, 10.1212/WNL.41.4.525
Muir, 1994, Anticardiolipin antibodies and cerebral infarction [letter], J. Neurol. Neurosurg. Psychiatry, 57, 253, 10.1136/jnnp.57.2.253
1993, Stroke, 24, I120
Metz, 1998, The frequency of phospholipid antibodies in an unselected stroke population, Can. J. Neurol. Sci., 25, 64, 10.1017/S0317167100033515
Zielinska, 1999, Anticardiolipin antibodies are an independent risk factor for ischemic stroke, Neurol. Res., 21, 653, 10.1080/01616412.1999.11740992
Yilmaz, 1994, Importance of serum anticardiolipin antibody levels in coronary heart disease, Clin. Cardiol., 17, 117, 10.1002/clc.4960170304
Puurunen, 1994, Antibody against oxidized low-density lipoprotein predicting myocardial infarction [published erratum appears inArch. Intern. Med . 1995, 155: 817], Arch. Intern. Med., 154, 2605, 10.1001/archinte.1994.00420220105012
Wu, 1977, Prophylaxis of deep venous thrombosis by hydroxychloroquine sulfate and heparin, Surg. Gynecol. Obstet., 145, 714
Laskin, C.A. Bombardier, C. Hannah, M.E. Mandel, F.P. Ritchie, J.W.K. Farewell, V. 1997, Prednisone and aspirin in women with autoantibodies and unexplained recurrent fetal loss, N. Eng. J. Med. 337, 148, 153
Scott, 1987, Anti-cardiolipin antibodies and pre-eclampsia, Br. J. Obstet. Gynaecol., 94, 604, 10.1111/j.1471-0528.1987.tb03162.x
Branch, 1992, Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience, Obstet. Gyencol., 80, 614
Cowchock, 1997, Autoantibodies and pregnancy loss [editorial], N. Engl. J. Med., 337, 197, 10.1056/NEJM199707173370311
Simpson, 1998, Lack of association between antiphospholipid antibodies and first-trimester spontaneous abortion: prospective study of pregnancies detected within 21 days of conception, Fertil. Steril., 69, 814, 10.1016/S0015-0282(98)00054-5
Teixido, 1997, Anti-beta 2-glycoprotein I antibodies: a useful marker for the antiphospholipid syndrome, Br. J. Rheumatol., 36, 113, 10.1093/rheumatology/36.1.113
Lynch, 1999, Association of antibodies to beta2-glycoprotein 1 with pregnancy loss and pregnancy-induced hypertension: a prospective study in low-risk pregnancy, Obstet. Gynecol., 93, 193, 10.1016/S0029-7844(98)00388-3